Increased thymocyte differentiation in myasthenia gravis: a dual-color immunofluorescence phenotypic analysis
- PMID: 2317013
- DOI: 10.1002/ana.410270213
Increased thymocyte differentiation in myasthenia gravis: a dual-color immunofluorescence phenotypic analysis
Abstract
Thymocytes express multiple, different surface antigens according to their stage of maturation. Surface differentiation antigens have been studied with the technique of simultaneous dual-color, direct immunofluorescence in the thymuses of 20 patients with myasthenia gravis (MG) and 10 control subjects with cardiac diseases. Fluorescein isothiocyanate-conjugated and phycoerythrin-conjugated monoclonal antibodies were used to stain thymic cell suspensions. A significant decrease in the percentage of immature and common thymocyte phenotypes (CD1+,3+ and CD4+,8+) and a significant increase in the percentage of mature thymocyte phenotypes (CD1-,3+; CD4+,8-; and CD4-,8+) and of B cells (CD20+) were found in MG thymuses compared with controls. These data, indicating an increased availability of mature, fully immunocompetent T and B cells, indirectly suggest the occurrence of an active immune response in MG thymus.
Similar articles
-
Increase in differentiated type of T lineage cells in the myasthenic thymus: two-color fluorocytometric analysis.Ann Neurol. 1990 Jun;27(6):642-6. doi: 10.1002/ana.410270610. Ann Neurol. 1990. PMID: 2113791
-
Intrathymic lymphoid cell differentiation in myasthenia gravis: an immunophenotypic study.Ital J Neurol Sci. 1991 Dec;12(6):569-73. doi: 10.1007/BF02336953. Ital J Neurol Sci. 1991. PMID: 1783535
-
Altered intrathymic T-cell repertoire in human myasthenia gravis.Ann Neurol. 1997 Jun;41(6):731-41. doi: 10.1002/ana.410410609. Ann Neurol. 1997. PMID: 9189034
-
Demonstration of phenotypic abnormalities of thymic epithelium in thymoma including two cases with abundant Langerhans cells.Am J Pathol. 1988 Sep;132(3):552-62. Am J Pathol. 1988. PMID: 3261946 Free PMC article.
-
Clinical applications of phenotypic analysis.Immunol Today. 1992 Aug;13(8):A27-8. doi: 10.1016/0167-5699(92)90065-F. Immunol Today. 1992. PMID: 1510808 Review.
Cited by
-
Thymus cells in myasthenia gravis: a two-colour flow cytometric analysis of lymphocytes in the thymus and thymoma.J Neurol. 1992 Feb;239(2):82-8. doi: 10.1007/BF00862978. J Neurol. 1992. PMID: 1552308
-
CD4+ T Cells of Myasthenia Gravis Patients Are Characterized by Increased IL-21, IL-4, and IL-17A Productions and Higher Presence of PD-1 and ICOS.Front Immunol. 2020 May 19;11:809. doi: 10.3389/fimmu.2020.00809. eCollection 2020. Front Immunol. 2020. PMID: 32508812 Free PMC article.
-
Galectin-1 is expressed by thymic epithelial cells in myasthenia gravis.Glycoconj J. 1996 Aug;13(4):591-7. doi: 10.1007/BF00731447. Glycoconj J. 1996. PMID: 8872116
-
Identification of potential prognostic biomarkers of thymoma with myasthenia gravis based on serum proteomics.Front Immunol. 2025 Jun 17;16:1580219. doi: 10.3389/fimmu.2025.1580219. eCollection 2025. Front Immunol. 2025. PMID: 40599774 Free PMC article.
-
Actuarial analysis of the occurrence of remissions following thymectomy for myasthenia gravis in 400 patients.J Neurol Neurosurg Psychiatry. 1991 May;54(5):406-11. doi: 10.1136/jnnp.54.5.406. J Neurol Neurosurg Psychiatry. 1991. PMID: 1865202 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials